• Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised to $441.00 at UBS Group

    Source: Buzz FX / 01 Nov 2024 15:27:15   America/New_York


    Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised to $441.00 at UBS Group Written by MarketBeat November 1, 2024 Share Link copied to clipboard. Madrigal Pharmaceuticals ( NASDAQ:MDGL - Get Free Report ) had its target price booste
    Read more...
Share on,